Saneron CCEL Therapeutics
About Saneron CCEL Therapeutics
Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options. Saneron, a University of South Florida spin-out company is located at the Tampa Bay Technology Incubator. An affiliate of Cryo-Cell International, Inc. Saneron is committed to providing readily available, non-controversial, ethically acceptable cells, both stem cells and other cell types, for cellular therapies. Saneron has patented and patent-pending technology relating to their platform technology
Company Facts
- Legal name: Saneron CCEL Therapeutics Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Website: saneron-ccel.com
- Phone: +1 813-977-7664
Social Profiles
Canonical: https://fsome.com/organization/saneron-ccel-therapeutics-8286223 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.